| Financial Year |
March 31 2023 |
| Monetary Funds |
967,655,029.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
656,312,770.58 |
| Advances to Suppliers |
213,458,281.94 |
| Other Receivables |
48,429,961.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
636,105,521.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
88,269,696.80 |
| Total Current Assets |
2,676,746,240.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
30,000,000.00 |
| Long-term Equity Investment |
850,339,418.15 |
| Investment Properties |
-- |
| Fixed Assetes |
5,697,399,486.90 |
| Under-construction Projects |
688,193,848.35 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
211,171,228.60 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
89,467,064.52 |
| Deferred Income Tax Assets |
70,564,651.69 |
| Other Non-Current Assets |
132,996,833.64 |
| Sub-Total of Non-Current Assets |
8,108,097,711.69 |
| Total Assets |
10,784,843,952.35 |
| Short-Term Loans |
1,906,150,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,009,000,000.00 |
| Accounts Payable |
1,528,867,794.68 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
38,865,632.04 |
| Taxes Payable |
12,497,052.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
92,752,801.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
384,989,468.30 |
| Other Current Liabilities |
50,000,000.00 |
| Sub-Total of Current Liabilities |
5,055,173,860.70 |
| Long-term Loans |
1,052,300,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
77,628,452.95 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,387,037,128.47 |
| Total Liabilities |
6,442,210,989.17 |
| Paid-In Capital(Or Share Stock) |
2,458,868,343.00 |
| Capital Surplus |
2,347,471,841.61 |
| Surplus Reserve |
190,502,144.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-654,209,365.93 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,342,632,963.18 |
| Owner's Equity（Stockholder's Equity） |
4,342,632,963.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,784,843,952.35 |
